Novo Nordisk (NOVOB DC) to cut Ozempic and Wegovy prices by up to 50% starting January 2027, according to WSJ; WeGovy and Ozempic will list for USD 675/month
Importance
Level 1
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#NOVO NORDISK A/S#NOVOB.DC#IMPORTANT#FOREX#EQUITIES#METALS#EU SESSION#US SESSION#PHARMACEUTICALS#METALS & MINING#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#DXY#US EQUITIES#GLOBAL EQUITIES